Arbutus Biopharma ABUS
NASDAQ ABUS
$4.74 -0.05 (-0.94%)
As of: Oct 1, 2026 · 11:53 AM EDT

Arbutus Biopharma (ABUS) Non Operating Interest Expenses (2017 - 2026)

Updated

Arbutus Biopharma's Non Operating Interest Expenses was $18,000 in Q2 2026, down 35.7% from $28,000 a year earlier but up 5.9% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Non Operating Interest Expenses (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Arbutus Biopharma's Non Operating Interest Expenses was $76,000 through Jun 30, 2026, down 33.9% year-over-year; for FY2025, it was $97,000, down 29.2% from FY2024.

  • Non Operating Interest Expenses has now declined for five consecutive years, with a five-year compound annual growth rate of -52.5% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $137,000 in FY2024 (-70.2%), $459,000 in FY2023 (-73.4%), $1.73 million in FY2022 (-39.6%) and $2.86 million in FY2021 (-28.8%).
  • Quarterly Non Operating Interest Expenses has moved between $17,000 (Q1 2026) and $762,000 (Q3 2021) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for 24 straight quarters, with an average decline of 32.3% over the last eight quarters.
  • Over the past five years, the year-over-year decline in Non Operating Interest Expenses ranged from 17.6% (Q2 2025) to 89.3% (Q3 2023).
  • Per Business Quant data, ABUS's Non Operating Interest Expenses in the three quarters before Q2 2026 was $17,000 (Q1 2026), $18,000 (Q4 2025) and $23,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Arbutus Biopharma 944.69 Mn 571.67 Mn - 18,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18,000.00
Mar 31, 2026 17,000.00
Dec 31, 2025 18,000.00
Sep 30, 2025 23,000.00
Jun 30, 2025 28,000.00
Mar 31, 2025 28,000.00
Dec 31, 2024 30,000.00
Sep 30, 2024 29,000.00
Jun 30, 2024 34,000.00
Mar 31, 2024 44,000.00
Dec 31, 2023 44,000.00
Sep 30, 2023 46,000.00
Jun 30, 2023 171,000.00
Mar 31, 2023 198,000.00
Dec 31, 2022 309,000.00
Sep 30, 2022 429,000.00
Jun 30, 2022 482,000.00
Mar 31, 2022 506,000.00
Dec 31, 2021 560,000.00
Sep 30, 2021 762,000.00
API Access

Arbutus Biopharma Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ABUS&period=max&api_key=YOUR_API_KEY